US Stock MarketDetailed Quotes
SGMT Sagimet Biosciences
- 5.130
- -0.060-1.16%
Close Oct 15 16:00 ET
- 5.100
- -0.030-0.58%
Post 19:19 ET
165.16MMarket Cap-5594P/E (TTM)
5.493High5.060Low1.22MVolume5.260Open5.190Pre Close6.39MTurnover7.40%Turnover RatioLossP/E (Static)32.20MShares20.71052wk High0.90P/B84.54MFloat Cap2.13052wk Low--Dividend TTM16.48MShs Float20.710Historical High--Div YieldTTM8.35%Amplitude2.130Historical Low5.235Avg Price1Lot Size
Sagimet Biosciences Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | 798.92%166.37M | 667.03%193.71M | 193.39%94.9M | 193.39%94.9M | --101.84M | --18.51M | --25.25M | -42.99%32.35M | --32.35M | -17.42%56.73M |
| -Cash and cash equivalents | 418.47%95.96M | 1,332.78%176.78M | 47,456.33%75.14M | 47,456.33%75.14M | --101.84M | --18.51M | --12.34M | -99.72%158K | --158K | -17.42%56.73M |
| -Short-term investments | --70.41M | 31.06%16.93M | -38.61%19.76M | -38.61%19.76M | --0 | --0 | --12.92M | --32.19M | --32.19M | --0 |
| Prepaid assets | 143.14%248K | 79.37%678K | 227.36%1.35M | 227.36%1.35M | --897K | --102K | --378K | -2.36%413K | --413K | --423K |
| Current deferred assets | --0 | --0 | --323K | --323K | ---- | --2.64M | --1.33M | --0 | --0 | --1.43M |
| Other current assets | 21.50%130K | 30.12%108K | 117.65%74K | 117.65%74K | --77K | --107K | --83K | -59.52%34K | --34K | 133.33%84K |
| Total current assets | 680.89%166.75M | 619.06%194.49M | 194.72%96.65M | 194.72%96.65M | --102.82M | --21.35M | --27.05M | -44.10%32.79M | --32.79M | -14.66%58.66M |
| Non current assets | ||||||||||
| Net PPE | 4.86%151K | -79.21%37K | -65.57%73K | -65.57%73K | --109K | --144K | --178K | -38.01%212K | --212K | 76.29%342K |
| -Gross PPE | 4.86%151K | -79.21%37K | -65.57%73K | -65.57%73K | --109K | --144K | --178K | -38.01%212K | --212K | 76.29%342K |
| Investments and advances | --22.12M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Non current prepaid assets | ---- | ---- | --0 | --0 | --0 | --0 | --27K | 0.00%27K | --27K | 0.00%27K |
| Total non current assets | 15,364.58%22.27M | -81.95%37K | -69.46%73K | -69.46%73K | --109K | --144K | --205K | -35.23%239K | --239K | 66.97%369K |
| Total assets | 779.24%189.02M | 613.79%194.53M | 192.81%96.72M | 192.81%96.72M | --102.93M | --21.5M | --27.25M | -44.05%33.03M | --33.03M | -14.40%59.03M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -26.77%1.99M | -63.66%531K | -83.47%186K | -83.47%186K | --1.7M | --2.72M | --1.46M | 47.83%1.13M | --1.13M | 48.34%761K |
| -accounts payable | -26.77%1.99M | -63.66%531K | -83.47%186K | -83.47%186K | --1.7M | --2.72M | --1.46M | 47.83%1.13M | --1.13M | 48.34%761K |
| Current accrued expenses | 53.86%3.57M | 12.24%3.95M | 30.42%5.17M | 30.42%5.17M | --3.15M | --2.32M | --3.52M | 189.34%3.96M | --3.96M | 35.78%1.37M |
| Current debt and capital lease obligation | 9.29%153K | -81.02%26K | -51.13%65K | -51.13%65K | --103K | --140K | --137K | 7.26%133K | --133K | -14.48%124K |
| -Current capital lease obligation | 9.29%153K | -81.02%26K | -51.13%65K | -51.13%65K | --103K | --140K | --137K | 7.26%133K | --133K | -14.48%124K |
| Other current liabilities | -90.29%10K | ---- | 308.77%233K | 308.77%233K | --95K | --103K | --167K | -69.19%57K | --57K | -23.87%185K |
| Current liabilities | 8.34%5.73M | -14.70%4.51M | 7.10%5.65M | 7.10%5.65M | --5.05M | --5.29M | --5.29M | 116.35%5.28M | --5.28M | 27.75%2.44M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | ---- | ---- | --0 | --0 | --0 | --0 | --39K | -65.18%78K | --78K | 244.62%224K |
| -Long term capital lease obligation | ---- | ---- | --0 | --0 | --0 | --0 | --39K | -65.18%78K | --78K | 244.62%224K |
| Derivative product liabilities | ---- | ---- | --0 | --0 | --1K | ---- | ---- | --4K | --4K | ---- |
| Preferred securities outside stock equity | ---- | ---- | --0 | --0 | --0 | --214.63M | --214.63M | -0.00%214.62M | --214.62M | 5.78%214.63M |
| Total non current liabilities | --0 | --0 | --0 | --0 | --1K | --214.63M | --214.67M | -0.07%214.7M | --214.7M | 5.86%214.85M |
| Total liabilities | -97.40%5.73M | -97.95%4.51M | -97.43%5.65M | -97.43%5.65M | --5.05M | --219.91M | --219.95M | 1.24%219.98M | --219.98M | 6.06%217.29M |
| Shareholders'equity | ||||||||||
| Share capital | 200.00%3K | 200.00%3K | 100.00%2K | 100.00%2K | --2K | --1K | --1K | 0.00%1K | --1K | 0.00%1K |
| -common stock | 200.00%3K | 200.00%3K | 100.00%2K | 100.00%2K | --2K | --1K | --1K | 0.00%1K | --1K | 0.00%1K |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | ---- | ---- | --0 | --0 | ---- |
| Retained earnings | -12.43%-264.49M | -12.22%-256.37M | -12.56%-249.74M | -12.56%-249.74M | ---241.59M | ---235.24M | ---228.46M | -15.94%-221.87M | ---221.87M | -14.64%-191.37M |
| Paid-in capital | 1,116.03%447.8M | 1,147.99%446.38M | 873.62%340.78M | 873.62%340.78M | --339.47M | --36.83M | --35.77M | 5.71%35M | --35M | 6.75%33.11M |
| Gains losses not affecting retained earnings | ---23K | 153.85%7K | 135.71%30K | 135.71%30K | --0 | --0 | ---13K | ---84K | ---84K | --0 |
| Total stockholders'equity | 192.38%183.29M | 198.61%190.02M | 148.71%91.07M | 148.71%91.07M | --97.88M | ---198.41M | ---192.7M | -18.13%-186.95M | ---186.95M | -16.44%-158.26M |
| Total equity | 192.38%183.29M | 198.61%190.02M | 148.71%91.07M | 148.71%91.07M | --97.88M | ---198.41M | ---192.7M | -18.13%-186.95M | ---186.95M | -16.44%-158.26M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
